Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cognitive and psychomotor effects of LY2624803 after bedtime dosing in healthy volunteers
NL-OMON31867Not yet recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of LY-2624803, zolpidem and diphenhydramine in Insomnia and sleep disorder (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Cognitive and psychomotor effects after bedtime dosing. Planned start Aug 2008; status: not yet recruiting.
02
Drugs
LY-2624803zolpidemdiphenhydramine
03
Conditions
Insomniasleep disorder
Beyond the preview
Go deeper on NL-OMON31867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31867.